Hacker News Reader

If they were indeed giving deadly doses of the drug by accident, it’s no wonder they stopped the study cold turkey.

That statement is not correct because it does not take into account the pharmacokinetics of the drug.

See the discussion here[1] (from the person who wrote the open letter to Lancet on the now-retracted HCQ study).

That’s a helpful link. Thx. Looks like no fatal doses.

But I wasn’t claiming they were doing so. I said “if” intentionally, since I know nothing about it.